Unlawful Distribution of Controlled Substances Resulting in Death:
HB 457 would amend Florida’s murder statute to create a new third-degree murder offense tied to the unlawful distribution of dangerous fentanyl or fentanyl analogs when that distribution causes, or is a substantial factor in causing, the death of the user. The bill defines “dangerous fentanyl or fentanyl analogs” by reference to existing controlled-substance provisions and adopts the existing statutory meaning of “distribute.” It applies only when the person who distributed the substance was under 18 years of age and knew or reasonably should have known the substance contained dangerous fentanyl or fentanyl analogs.
Under the bill, the conduct would be treated as murder in the third degree and classified as a second-degree felony, punishable under Florida’s standard felony sentencing laws. The bill would take effect July 1, 2025, and would add this new offense to section 782.04, Florida Statutes, while renumbering the current subsection structure accordingly.
The bill would expand Florida’s homicide law by creating a specific criminal offense for fatal fentanyl distribution by minors, adding a new pathway for prosecuting drug-related deaths under the murder statute rather than only under controlled-substance or manslaughter provisions. It would affect section 782.04, Florida Statutes, and incorporate definitions from chapter 893, linking homicide liability to existing drug-control terminology and sentencing provisions in chapters 775 and 893.
The available legislative history suggests the bill’s policy goal was broadly aligned with efforts to address fentanyl-related deaths, and it ultimately advanced through the companion measure that became law (CS/SB 612, Ch. 2025-69). There are no committee transcripts or recorded votes in the provided material, so the record here does not show detailed debate or opposition, but the final status indicates the House bill was laid on the table after the companion bill passed.
The main policy issue appears to be the scope of criminal liability for drug-induced deaths, especially the decision to limit this new murder offense to distributors under 18 years old and to require proof that the person knew or reasonably should have known the substance contained dangerous fentanyl or fentanyl analogs. Potential points of contention would likely include whether homicide charges are appropriate for juvenile distributors, how causation is proven when a substance is a “substantial factor” in death, and whether the bill overlaps with or duplicates existing drug-trafficking and homicide statutes. No specific objections or supporters are identified in the provided transcripts.